A U.S. study found that patients who received combined hormone replacement therapy for about five years are more likely to have abnormal mammograms and breast biopsies compared with those who received a placebo. The findings suggest that HRT may affect the efficacy of the tests in breast cancer diagnosis. One provider said that women need to be more aware of the risks involved in HRT.

Full Story:

Related Summaries